Real‐world use—Isavuconazole at a large academic medical center
Sign Up to like & getrecommendations! Published in 2019 at "Mycoses"
DOI: 10.1111/myc.12910
Abstract: Isavuconazole use in the real‐world setting has not been extensively described. Subgroups of patients with particular prognostic significance, such as previous triazole prophylaxis or treatment and the important subgroup treated empirically for invasive fungal infection,… read more here.
Keywords: use isavuconazole; real world; use; world use ... See more keywords
Use of isavuconazole in a patient with voriconazole‐induced QTc prolongation
Sign Up to like & getrecommendations! Published in 2017 at "Transplant Infectious Disease"
DOI: 10.1111/tid.12712
Abstract: A 22‐year‐old woman with cystic fibrosis developed QTc interval prolongation following lung transplantation in the setting of voriconazole therapy. After the discontinuation of voriconazole and initiation of isavuconazole, her QTc interval normalized. This case highlights… read more here.
Keywords: use isavuconazole; isavuconazole patient; voriconazole induced; qtc interval ... See more keywords
Isavuconazole for COVID-19-Associated Invasive Mold Infections
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Fungi"
DOI: 10.3390/jof8070674
Abstract: Isavuconazole is a broad-spectrum antifungal drug recently approved as a first-line treatment for invasive aspergillosis and as a first or alternative treatment for mucormycosis. The purpose of this review was to report and discuss the… read more here.
Keywords: therapy; covid; covid associated; use isavuconazole ... See more keywords